Molnupiravir, a direct-acting coronavirus drug, will be registered in Ukraine next week.
The medicine effectively helps fight the disease, and its deliveries are expected within 10 days, Minister of Health of Ukraine Viktor Lyashko said during a briefing following a meeting of the National Security and Defense Council.
"
After its registration, the drug will quickly try to distribute throughout Ukraine.
[see_also ids\u003d"
"
During studies, Molnupiravir has shown safety and efficacy in reducing the risk of hospitalization and patient death.. It is noted that the medicine is prescribed for adults who have symptoms of coronavirus and who are at risk of hospitalization, including the elderly and people with obesity and heart disease.. The medicine should not be taken by pregnant women.
Earlier it was reported that following the European regulator, the US Food and Drug Administration (FDA) allowed the use of the drug against COVID-19 from Merck company " This medicine has already become the second drug in the form of a capsule authorized in the United States..
At the same time, France canceled the order for the antiviral drug " The reason for the refusal was data from a study on the low effectiveness of pills, said French Health Minister Olivier Veran..